TW200804378A
(en)
*
|
2005-12-09 |
2008-01-16 |
Speedel Experimenta Ag |
Organic compounds
|
TW200813071A
(en)
*
|
2006-04-12 |
2008-03-16 |
Speedel Experimenta Ag |
Spiro-imidazo compounds
|
EP2024349B1
(de)
*
|
2006-05-31 |
2017-08-02 |
AbbVie Inc. |
Verbindungen als cannabinoid-rezeptorliganden und ihre verwendung
|
US8841334B2
(en)
*
|
2006-05-31 |
2014-09-23 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands and uses thereof
|
US8546583B2
(en)
*
|
2006-05-31 |
2013-10-01 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands and uses thereof
|
CN101765594A
(zh)
|
2007-03-28 |
2010-06-30 |
雅培制药有限公司 |
作为***素受体配体的1,3-噻唑-2(3h)-亚基化合物
|
BRPI0809645A2
(pt)
*
|
2007-03-29 |
2014-09-23 |
Novartis Ag |
Espoiro-composots heterocíclicos
|
US7872033B2
(en)
*
|
2007-04-17 |
2011-01-18 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands
|
US8501794B2
(en)
*
|
2007-04-17 |
2013-08-06 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
US8735434B2
(en)
*
|
2007-05-18 |
2014-05-27 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
US9193713B2
(en)
*
|
2007-10-12 |
2015-11-24 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
EP2274306A1
(de)
|
2008-03-11 |
2011-01-19 |
Abbott Laboratories |
Neue verbindungen als cannabinoidrezeptorliganden
|
US8653100B2
(en)
|
2008-04-01 |
2014-02-18 |
Abbvie Inc. |
Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
|
CA2731095A1
(en)
*
|
2008-08-05 |
2010-02-11 |
Abbott Laboratories |
Compounds useful as inhibitors of protein kinases
|
CA2731102A1
(en)
|
2008-08-15 |
2010-02-18 |
Abbott Laboratories |
Imine derivatives as cannabinoid receptor ligands
|
US8846730B2
(en)
|
2008-09-08 |
2014-09-30 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
JP2012502917A
(ja)
*
|
2008-09-16 |
2012-02-02 |
アボット・ラボラトリーズ |
カンナビノイド受容体リガンドとしての置換ベンズアミド類
|
MX2011004090A
(es)
*
|
2008-10-17 |
2011-05-31 |
Abbott Lab |
Antagonistas trpv1.
|
JP2012505907A
(ja)
*
|
2008-10-17 |
2012-03-08 |
アボット・ラボラトリーズ |
Trpv1拮抗薬
|
US20100160322A1
(en)
|
2008-12-04 |
2010-06-24 |
Abbott Laboratories |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
UA108193C2
(uk)
|
2008-12-04 |
2015-04-10 |
|
Апоптозіндукуючий засіб для лікування раку і імунних і аутоімунних захворювань
|
US8557983B2
(en)
|
2008-12-04 |
2013-10-15 |
Abbvie Inc. |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
US8586754B2
(en)
|
2008-12-05 |
2013-11-19 |
Abbvie Inc. |
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
|
EP3101019A1
(de)
|
2008-12-05 |
2016-12-07 |
AbbVie Inc. |
Sulfonamides derivate als bcl-2-selektive apoptoseinduktoren zur behandlung von krebs sowie von immunerkrankungen
|
US8563735B2
(en)
*
|
2008-12-05 |
2013-10-22 |
Abbvie Inc. |
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
|
PA8854001A1
(es)
|
2008-12-16 |
2010-07-27 |
Abbott Lab |
Compuestos novedosos como ligandos de receptores de canabinoides
|
AU2010204555B2
(en)
|
2009-01-19 |
2013-03-07 |
Abbvie Inc. |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
KR20160066014A
(ko)
|
2009-01-19 |
2016-06-09 |
애브비 인코포레이티드 |
암, 면역 질환 및 자가면역 질환의 치료를 위한 아폽토시스-유도제
|
TW201038569A
(en)
|
2009-02-16 |
2010-11-01 |
Abbott Gmbh & Co Kg |
Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
|
AR075442A1
(es)
|
2009-02-16 |
2011-03-30 |
Abbott Gmbh & Co Kg |
Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
|
TWI519530B
(zh)
|
2009-02-20 |
2016-02-01 |
艾伯維德國有限及兩合公司 |
羰醯胺化合物及其作為鈣蛋白酶(calpain)抑制劑之用途
|
US8236822B2
(en)
*
|
2009-03-27 |
2012-08-07 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands
|
CN102448957A
(zh)
*
|
2009-03-27 |
2012-05-09 |
雅培制药有限公司 |
作为***素受体配体的化合物
|
ES2540119T3
(es)
*
|
2009-03-27 |
2015-07-08 |
Abbvie Inc. |
Compuestos como ligandos de receptores cannabinoides
|
US8507493B2
(en)
*
|
2009-04-20 |
2013-08-13 |
Abbvie Inc. |
Amide and amidine derivatives and uses thereof
|
US8236798B2
(en)
|
2009-05-07 |
2012-08-07 |
Abbott Gmbh & Co. Kg |
Carboxamide compounds and their use as calpain inhibitors
|
US8546399B2
(en)
|
2009-05-26 |
2013-10-01 |
Abbvie Inc. |
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
|
SG175253A1
(en)
|
2009-05-26 |
2011-11-28 |
Abbott Lab |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
US20220315555A1
(en)
|
2009-05-26 |
2022-10-06 |
Abbvie Inc. |
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
|
US9034875B2
(en)
|
2009-05-26 |
2015-05-19 |
Abbvie Inc. |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
EA201101672A1
(ru)
|
2009-05-28 |
2012-06-29 |
Новартис Аг |
Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина
|
DK2435409T3
(da)
|
2009-05-28 |
2014-10-27 |
Novartis Ag |
Substituerede aminopropionsyrederivater som neprilysininhibitorer
|
US8962639B2
(en)
*
|
2009-05-29 |
2015-02-24 |
Abbvie Inc. |
Potassium channel modulators
|
WO2011053740A1
(en)
|
2009-10-28 |
2011-05-05 |
Belkin International, Inc. |
Portable multi-media communication device protective carrier and method of manufacture therefor
|
JO2967B1
(en)
|
2009-11-20 |
2016-03-15 |
نوفارتس ايه جي |
Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
|
WO2011066168A1
(en)
|
2009-11-25 |
2011-06-03 |
Abbott Laboratories |
Potassium channel modulators
|
TW201130855A
(en)
|
2009-12-16 |
2011-09-16 |
Abbott Lab |
Prodrug compounds useful as cannabinoid ligands
|
AU2011229862B2
(en)
|
2010-03-25 |
2014-07-24 |
Abbvie Inc. |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
TWI520960B
(zh)
|
2010-05-26 |
2016-02-11 |
艾伯維有限公司 |
用於治療癌症及免疫及自體免疫疾病之細胞凋亡誘導劑
|
US8586596B2
(en)
|
2010-06-15 |
2013-11-19 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
CA2807538A1
(en)
|
2010-08-10 |
2012-02-16 |
Abbvie Inc. |
Novel trpv3 modulators
|
US9051280B2
(en)
|
2010-08-13 |
2015-06-09 |
AbbVie Deutschland GmbH & Co. KG |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US8883839B2
(en)
|
2010-08-13 |
2014-11-11 |
Abbott Laboratories |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US8846743B2
(en)
|
2010-08-13 |
2014-09-30 |
Abbott Laboratories |
Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US9045459B2
(en)
|
2010-08-13 |
2015-06-02 |
AbbVie Deutschland GmbH & Co. KG |
Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US8877794B2
(en)
|
2010-08-13 |
2014-11-04 |
Abbott Laboratories |
Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
JP5998142B2
(ja)
|
2010-09-27 |
2016-09-28 |
アボット ゲーエムベーハー ウント カンパニー カーゲー |
複素環化合物およびグリコーゲンシンターゼキナーゼ−3阻害薬としてのその使用
|
CA2811805A1
(en)
|
2010-10-29 |
2012-05-03 |
Abbvie Inc. |
Solid dispersions containing an apoptosis-inducing agent
|
UA113500C2
(xx)
|
2010-10-29 |
2017-02-10 |
|
Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб
|
WO2012059431A1
(en)
|
2010-11-01 |
2012-05-10 |
Abbott Gmbh & Co. Kg |
Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptor
|
WO2012059432A1
(en)
|
2010-11-01 |
2012-05-10 |
Abbott Gmbh & Co. Kg |
N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the 5-ht6 receptor
|
CN103313968A
(zh)
|
2010-11-15 |
2013-09-18 |
Abbvie公司 |
Nampt和rock抑制剂
|
US20120122924A1
(en)
|
2010-11-15 |
2012-05-17 |
Abbott Laboratories |
Nampt inhibitors
|
US8609669B2
(en)
|
2010-11-16 |
2013-12-17 |
Abbvie Inc. |
Potassium channel modulators
|
US8673974B2
(en)
|
2010-11-16 |
2014-03-18 |
Novartis Ag |
Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
|
US8609674B2
(en)
|
2010-11-16 |
2013-12-17 |
Abbvie Inc. |
Potassium channel modulators
|
US8877815B2
(en)
|
2010-11-16 |
2014-11-04 |
Novartis Ag |
Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
|
SI2643322T1
(en)
|
2010-11-23 |
2018-01-31 |
Abbvie Inc. |
Salts and crystalline forms of an apoptosis induction agent
|
HUE031267T2
(en)
|
2010-11-23 |
2017-06-28 |
Abbvie Ireland Unlimited Co |
Methods of treatment using selective BCL-2 inhibitors
|
US9090592B2
(en)
|
2010-12-30 |
2015-07-28 |
AbbVie Deutschland GmbH & Co. KG |
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
|
US8802693B1
(en)
|
2011-03-09 |
2014-08-12 |
Abbvie Inc. |
Azaadamantane derivatives and methods of use
|
WO2012129491A1
(en)
|
2011-03-24 |
2012-09-27 |
Abbott Laboratories |
Trpv3 modulators
|
AR085530A1
(es)
|
2011-03-25 |
2013-10-09 |
Abbott Lab |
Antagonistas del receptor transitorio potencial de vanilloides 1 (trpv1)
|
US9309200B2
(en)
|
2011-05-12 |
2016-04-12 |
AbbVie Deutschland GmbH & Co. KG |
Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US8859549B2
(en)
|
2011-05-13 |
2014-10-14 |
Abbvie, Inc. |
Potassium channel modulators
|
KR20140056258A
(ko)
|
2011-07-08 |
2014-05-09 |
노파르티스 아게 |
높은 트리글리세리드 대상체에서의 아테롬성동맥경화증의 치료 방법
|
WO2013020930A1
(en)
|
2011-08-05 |
2013-02-14 |
Abbott Gmbh & Co. Kg |
Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
|
TWI571466B
(zh)
|
2011-10-14 |
2017-02-21 |
艾伯維有限公司 |
用於治療癌症及免疫與自體免疫疾病之細胞凋亡誘發劑
|
TWI561521B
(en)
|
2011-10-14 |
2016-12-11 |
Abbvie Inc |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
WO2013062964A2
(en)
|
2011-10-24 |
2013-05-02 |
Abbvie Inc. |
Novel trpv3 modulators
|
US20130116241A1
(en)
|
2011-11-09 |
2013-05-09 |
Abbvie Inc. |
Novel inhibitor compounds of phosphodiesterase type 10a
|
CA2853254A1
(en)
|
2011-11-18 |
2013-05-23 |
Abbvie Inc. |
N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
WO2013096223A1
(en)
|
2011-12-19 |
2013-06-27 |
Abbvie Inc. |
Trpv1 antagonists
|
US8969325B2
(en)
|
2011-12-19 |
2015-03-03 |
Abbvie Inc. |
TRPV1 antagonists
|
US9365512B2
(en)
|
2012-02-13 |
2016-06-14 |
AbbVie Deutschland GmbH & Co. KG |
Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
|
WO2013149376A1
(en)
|
2012-04-02 |
2013-10-10 |
Abbott Laboratories |
Chemokine receptor antagonists
|
EP2838881B1
(de)
|
2012-04-20 |
2018-08-08 |
AbbVie Inc. |
Isoindolonderivate
|
JP2015520752A
(ja)
|
2012-05-11 |
2015-07-23 |
アッヴィ・インコーポレイテッド |
Nampt阻害薬としてのピリダジンおよびピリジン誘導体
|
KR20150007349A
(ko)
|
2012-05-11 |
2015-01-20 |
애브비 인코포레이티드 |
Nampt 억제제
|
EP2850081A1
(de)
|
2012-05-11 |
2015-03-25 |
AbbVie Inc. |
Thiazolcarboxamidderivate zur verwendung als nampt-hemmer
|
CN104684906B
(zh)
|
2012-05-11 |
2017-06-09 |
艾伯维公司 |
Nampt抑制剂
|
US20130317054A1
(en)
|
2012-05-24 |
2013-11-28 |
Abbvie Inc. |
Neuronal nicotinic agonist and methods of use
|
US20130317055A1
(en)
|
2012-05-24 |
2013-11-28 |
Abbvie Inc. |
Neuronal nicotinic agonist and methods of use
|
SG11201408324QA
(en)
|
2012-06-12 |
2015-01-29 |
Abbvie Inc |
Pyridinone and pyridazinone derivatives
|
US8796328B2
(en)
|
2012-06-20 |
2014-08-05 |
Abbvie Inc. |
TRPV1 antagonists
|
MX2015003364A
(es)
|
2012-09-14 |
2016-03-31 |
Abbvie Deutschland |
Derivados triciclicos de quinolinas y de quinoxalinas.
|
US20140080813A1
(en)
|
2012-09-14 |
2014-03-20 |
AbbVie Deutschland GmbH & Co. KG |
Tricyclic quinoline and quinoxaline derivatives
|
UY35144A
(es)
|
2012-11-20 |
2014-06-30 |
Novartis Ag |
Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca
|
HUE038248T2
(hu)
|
2013-02-14 |
2018-10-29 |
Novartis Ag |
Helyettesített biszfenil-bután-foszfonsav származékok, mint NEP (semleges endopeptidáz) inhibitorok
|
US8969375B2
(en)
|
2013-03-13 |
2015-03-03 |
Abbvie, Inc. |
CDK9 kinase inhibitors
|
TW201444820A
(zh)
|
2013-03-13 |
2014-12-01 |
Abbvie Inc |
吡啶cdk9激酶抑制劑
|
US20140275082A1
(en)
|
2013-03-14 |
2014-09-18 |
Abbvie Inc. |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
JP2016512560A
(ja)
|
2013-03-14 |
2016-04-28 |
アッヴィ・インコーポレイテッド |
ピロロピリミジン系cdk9キナーゼ阻害薬
|
TW201444836A
(zh)
|
2013-03-14 |
2014-12-01 |
Abbvie Inc |
吡咯并[2,3-b]吡啶cdk9激酶抑制劑
|
AR101528A1
(es)
|
2013-03-14 |
2016-12-28 |
Abbvie Inc |
Inhibidores de cdk9 quinasa de pirrolo[2,3-b]piridina
|
US9163019B2
(en)
|
2013-03-14 |
2015-10-20 |
AbbVie Deutschland GmbH & Co. KG |
Inhibitor compounds of phosphodiesterase type 10A
|
BR112015023016A2
(pt)
|
2013-03-14 |
2017-07-18 |
Abbvie Deutschland |
derivados de oxindolo carregando um substituinte oxetano e uso do mesmo para tratamento de doenças relacionadas a vasopressina
|
US9650334B2
(en)
|
2013-03-15 |
2017-05-16 |
Abbvie Inc. |
Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US9656955B2
(en)
|
2013-03-15 |
2017-05-23 |
Abbvie Inc. |
Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
TN2016000031A1
(en)
|
2013-07-25 |
2017-07-05 |
Novartis Ag |
Cyclic polypeptides for the treatment of heart failure
|
CN105705167A
(zh)
|
2013-07-25 |
2016-06-22 |
诺华股份有限公司 |
合成的apelin多肽的生物缀合物
|
JP2016533375A
(ja)
|
2013-10-17 |
2016-10-27 |
アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー |
アミノテトラリン誘導体およびアミノインダン誘導体、これらを含有する医薬組成物、および治療におけるこれらの使用
|
CN105992764A
(zh)
|
2013-10-17 |
2016-10-05 |
艾伯维德国有限责任两合公司 |
氨基色满、氨基硫代色满及氨基-1,2,3,4-四氢喹啉衍生物,包含其的药物组合物及其在治疗中的用途
|
WO2015091931A1
(en)
|
2013-12-20 |
2015-06-25 |
AbbVie Deutschland GmbH & Co. KG |
Oxindole derivatives carrying a piperidyl-substituted azetidinyl substituent and use thereof for treating vasopressine-related diseases
|
US9328112B2
(en)
|
2014-02-06 |
2016-05-03 |
Abbvie Inc. |
Tetracyclic CDK9 kinase inhibitors
|
US9617226B2
(en)
|
2014-09-05 |
2017-04-11 |
AbbVie Deutschland GmbH & Co. KG |
Fused heterocyclic or carbocyclic compounds carrying a substituted cycloaliphatic radical and use thereof for treating vasopressin-related diseases
|
US9550754B2
(en)
|
2014-09-11 |
2017-01-24 |
AbbVie Deutschland GmbH & Co. KG |
4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy
|
CN107406490A
(zh)
|
2015-01-23 |
2017-11-28 |
诺华股份有限公司 |
具有改善的半衰期的合成apelin脂肪酸缀合物
|
US20180243298A1
(en)
|
2015-04-02 |
2018-08-30 |
Abbvie Inc. |
Trpv3 modulators
|
US20180339996A1
(en)
|
2015-11-25 |
2018-11-29 |
AbbVie Deutschland GmbH & Co. KG |
Hexahydropyrazinobenz- or -pyrido-oxazepines carrying an oxygen-containing substituent and use thereof in the treatment of 5-ht2c-dependent disorders
|
BR112018072699A2
(pt)
|
2016-05-07 |
2019-02-19 |
Shanghai Fochon Pharmaceutical Co., Ltd. |
determinados inibidores de proteína cinase
|
JOP20190086A1
(ar)
|
2016-10-21 |
2019-04-18 |
Novartis Ag |
مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب
|
CN110139857B
(zh)
|
2016-11-28 |
2023-07-21 |
重庆复尚源创医药技术有限公司 |
作为吲哚胺2,3-双加氧酶抑制剂的亚砜亚胺、磺酰亚胺酰胺、磺酰二亚胺和二酰亚胺磺酰胺化合物
|
US20200039930A1
(en)
|
2017-03-21 |
2020-02-06 |
AbbVie Deutschland GmbH & Co. KG |
Proline amide compounds and their azetidine analogues carrying a specifically substituted benzyl radical
|
HRP20221158T1
(hr)
|
2017-04-18 |
2022-12-09 |
Shanghai Fochon Pharmaceutical Co., Ltd. |
Sredstva za izazivanje apoptoze
|
UY38072A
(es)
|
2018-02-07 |
2019-10-01 |
Novartis Ag |
Compuestos derivados de éster butanoico sustituido con bisfenilo como inhibidores de nep, composiciones y combinaciones de los mismos
|
JP7294677B2
(ja)
|
2018-03-14 |
2023-06-20 |
フォチョン・ファーマシューティカルズ・リミテッド |
TRKキナーゼ阻害剤としての置換(2-アザビシクロ[3.1.0]ヘキサン-2-イル)ピラゾロ[1,5-a]ピリミジン化合物及び置換(2-アザビシクロ[3.1.0]ヘキサン-2-イル)イミダゾ[1,2-b]ピリダジン化合物
|
CA3092749A1
(en)
|
2018-03-23 |
2019-09-26 |
Fochon Pharmaceuticals, Ltd. |
Deuterated compounds as rock inhibitors
|
JP2022509184A
(ja)
|
2018-11-27 |
2022-01-20 |
ノバルティス アーゲー |
代謝性障害の処置のためのプロタンパク質コンバターゼスブチリシン/ケキシン9型(pcsk9)阻害剤としての環状ペプチド
|
CN113166101A
(zh)
|
2018-11-27 |
2021-07-23 |
诺华股份有限公司 |
作为治疗代谢障碍的蛋白质原转换酶枯草杆菌蛋白酶/kexin 9型(PCSK9)抑制剂的环状五聚体化合物
|
UY38485A
(es)
|
2018-11-27 |
2020-06-30 |
Novartis Ag |
Compuestos tetrámeros cíclicos como inhibidores de proproteína convertasa subtilisina/kexina tipo 9 (pcsk9), método de tratamiento, uso y su preparación
|
TW202333563A
(zh)
|
2021-11-12 |
2023-09-01 |
瑞士商諾華公司 |
用於治療疾病或障礙之二胺基環戊基吡啶衍生物
|
AR127698A1
(es)
|
2021-11-23 |
2024-02-21 |
Novartis Ag |
Derivados de naftiridinona para el tratamiento de una enfermedad o un trastorno
|